Advertisement
Research ArticleBehavioral Pharmacology

The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits

J. M. Witkin, J. A. Monn, D. D. Schoepp, X. Li, C. Overshiner, S. N. Mitchell, G. Carter, B. Johnson, K. Rasmussen and L. M. Rorick-Kehn
Journal of Pharmacology and Experimental Therapeutics July 2016, 358 (1) 71-82; DOI: https://doi.org/10.1124/jpet.116.233627

Article Information

vol. 358 no. 1 71-82
DOI 
https://doi.org/10.1124/jpet.116.233627
PubMed 
27189960
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received March 18, 2016
  • Accepted May 10, 2016
  • Published online June 8, 2016.

Article Versions

Copyright & Usage 
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. J. M. Witkin,
  2. J. A. Monn,
  3. D. D. Schoepp,
  4. X. Li,
  5. C. Overshiner,
  6. S. N. Mitchell,
  7. G. Carter,
  8. B. Johnson,
  9. K. Rasmussen, and
  10. L. M. Rorick-Kehn
  1. Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  1. Address correspondence to:
    Dr. Jeffrey M. Witkin, Lilly Research Laboratories; Lilly Corporate Center, Indianapolis, IN 46285-0510. E-mail: jwitkin{at}lilly.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2016 to September 2024

AbstractFullPdf
May 20163051189
Jun 201684048164
Jul 20161623539
Aug 20161301325
Sep 2016871420
Oct 20161272119
Nov 201667198
Dec 2016242115
Jan 2017571410
Feb 20171012622
Mar 2017242326
Apr 2017521412
May 2017291919
Jun 201753014
Jul 2017316242
Aug 2017519235
Sep 2017524946
Oct 201753329
Nov 201737344
Dec 201744717
Jan 201845022
Feb 201856532
Mar 201886732
Apr 2018540430
May 2018615647
Jun 201839127
Jul 2018112637
Aug 201856843
Sep 201853715
Oct 201855919
Nov 201836623
Dec 201836419
Jan 201995416
Feb 201957425
Mar 201956536
Apr 201975534
May 201923516
Jun 201933129
Jul 201943430
Aug 201953623
Sep 201935330
Oct 2019113922
Nov 201924027
Dec 201972315
Jan 202022410
Feb 202015023
Mar 202073121
Apr 202083231
May 202074031
Jun 202051313
Jul 202092016
Aug 202031916
Sep 20201010011
Oct 20205338
Nov 202042614
Dec 2020112613
Jan 202143510
Feb 2021122223
Mar 2021133510
Apr 2021152115
May 2021233619
Jun 202110268
Jul 202162716
Aug 202172015
Sep 202141718
Oct 202124117
Nov 202182430
Dec 2021133624
Jan 202242134
Feb 202253510
Mar 202283316
Apr 202282321
May 202282919
Jun 2022512111
Jul 20225864
Aug 20227895
Sep 202239111
Oct 202263123
Nov 20222310
Dec 20222755
Jan 20235394
Feb 202311583
Mar 20236386
Apr 20238075
May 20232554
Jun 20233742
Jul 20233451
Aug 20231961
Sep 20232092
Oct 20233826
Nov 202321067
Dec 2023137134
Jan 202455127
Feb 202465145
Mar 2024128912
Apr 202488124
May 2024237224
Jun 2024160152
Jul 202449177
Aug 20248143
Sep 20241000

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleBehavioral Pharmacology

Rapidly Acting Antidepressant Actions of LY341495

J. M. Witkin, J. A. Monn, D. D. Schoepp, X. Li, C. Overshiner, S. N. Mitchell, G. Carter, B. Johnson, K. Rasmussen and L. M. Rorick-Kehn
Journal of Pharmacology and Experimental Therapeutics July 1, 2016, 358 (1) 71-82; DOI: https://doi.org/10.1124/jpet.116.233627
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement